Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy

The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity,...

Full description

Bibliographic Details
Main Author: Dimitri Poddighe
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Journal of Microbiology, Immunology and Infection
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118219300489
id doaj-def2f75a3dd7426a8035a601ee454725
record_format Article
spelling doaj-def2f75a3dd7426a8035a601ee4547252020-11-25T02:40:01ZengElsevierJournal of Microbiology, Immunology and Infection1684-11822020-02-01531188189Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapyDimitri Poddighe0Department of Medicine, Nazarbayev University School of Medicine, Kerei-Zhanibek Str. 5/1, 010000, Astana, KazakhstanThe findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae. Keywords: Extra-pulmonary diseases, Immune-mediated diseases, Mycoplasma pneumoniaehttp://www.sciencedirect.com/science/article/pii/S1684118219300489
collection DOAJ
language English
format Article
sources DOAJ
author Dimitri Poddighe
spellingShingle Dimitri Poddighe
Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
Journal of Microbiology, Immunology and Infection
author_facet Dimitri Poddighe
author_sort Dimitri Poddighe
title Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
title_short Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
title_full Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
title_fullStr Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
title_full_unstemmed Mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
title_sort mycoplasma pneumoniae-related extra-pulmonary diseases and antimicrobial therapy
publisher Elsevier
series Journal of Microbiology, Immunology and Infection
issn 1684-1182
publishDate 2020-02-01
description The findings by Yang-TI et al. suggested that macrolide-resistance and/or delayed appropriate antimicrobial treatment may contribute to the development of Mycoplasma pneumoniae-related extra-pulmonary diseases in children. Indeed, these conditions can have variable clinical expression and severity, and may arise in immunologically predisposed children after recurrent/persistent exposure to Mycoplasma pneumoniae. Keywords: Extra-pulmonary diseases, Immune-mediated diseases, Mycoplasma pneumoniae
url http://www.sciencedirect.com/science/article/pii/S1684118219300489
work_keys_str_mv AT dimitripoddighe mycoplasmapneumoniaerelatedextrapulmonarydiseasesandantimicrobialtherapy
_version_ 1724783498357637120

Similar Items